Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer [Phase 2]
Phase 2 trial exploring dalpiciclib in combination with exemestane, trastuzumab, and pyrotinib for early triple-positive breast cancer (ER+,…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors [Phase 2]
Phase II trial update of talazoparib in BRCA1/2 wild-type, HER2-negative breast cancer and other solid tumors has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer [Phase 2]
Phase 2 clinical trial update for pyrotinib in neoadjuvant therapy for HR-positive and HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer [Phase 3]
Phase 3 trial evaluating pharmacokinetics, efficacy, and safety of a subcutaneous fixed-dose combination of pertuzumab and trastuzumab with …
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer [Phase 1]
Phase 1 trial results for a three-drug combination of fulvestrant, palbociclib, and erdafitinib in ER+/HER2-/FGFR-amplified metastatic breas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC [Phase 2]
A Phase 2 clinical trial evaluating sintilimab and bevacizumab biosimilar in combination with pegylated liposomal doxorubicin for metastatic…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating G1T38 (a CDK 4/6 inhibitor) in combination with fulvestrant for HR-positive, HER2-negative locally adv…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer [Phase 2]
A phase 2 clinical trial evaluating disitamab vedotin combined with penpulimab as neoadjuvant therapy for HER2-low breast cancer is underway…
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib [Phase 2]
Phase 2 trial updating colon pathology in patients with HER2-amplified breast cancer treated with neratinib has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: NSAID Effects on Clinical and Imaging Breast Biomarkers [Phase 2]
Phase 2 trial evaluating NSAID effects on clinical and imaging breast biomarkers; completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy [NA]
Clinical trial update on using diffusion-weighted imaging to assess treatment response in breast cancer patients receiving neoadjuvant chemo…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. [Phase 4]
Phase 4 clinical trial evaluating ultrasound-guided multiple-injection costotransverse block for mastectomy and primary reconstructive surge…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer [Phase 3]
A Phase 3 clinical trial comparing SYSA1901 to Perjeta in HER2-positive breast cancer is underway, with the status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating whether local treatments (surgery or high-dose radiation) to metastatic sites in breast cancer i…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer [Phase 2]
Phase II trial of Doxil (liposomal doxorubicin), carboplatin, and bevacizumab in untreated metastatic breast cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer [Phase 2]
Phase 2 trial evaluating prevention of cardiovascular diseases in women with breast cancer undergoing complex treatment; completed.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD [Phase 2]
A Phase 2 trial of tucatinib, trastuzumab, and capecitabine for HER2-positive leptomeningeal disease in metastatic breast cancer was termina…
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel [Phase 2, Phase 3]
Clinical trial update for Balugrastim (Neugranin) in breast cancer patients receiving doxorubicin/docetaxel; Phase 2/3 completed with result…
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) [Phase 2]
Phase 2 trial comparing giredestrant plus palbociclib to anastrozole plus palbociclib in untreated postmenopausal ER-positive, HER2-negative…
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer [NA]
Clinical trial comparing early surgery versus standard palliative therapy in patients with stage IV breast cancer has completed; results pos…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial in breast cancer, including triple-negative cases, evaluated carboplatin/paclitaxel followed by doxorubicin/cycl…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Breast Cup Immobilization Device II (GCC 1047)
A completed clinical trial involves a Breast Cup Immobilization Device (GCC 1047) for breast cancer; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA) [Phase 2]
Phase 2 trial of pembrolizumab plus carboplatin in metastatic breast cancer (PEMBRACA) has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: MRI-Based Preoperative Accelerated Partial Breast Irradiation [NA]
Clinical trial update for MRI-based preoperative accelerated partial breast irradiation in breast cancer, with results posted in January 202…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Thero2-01S22 in HER2-positive Breast Cancer [Phase 3]
Phase 3 trial update for Thero2-01S22 in HER2-positive breast cancer (not yet recruiting).